Your browser doesn't support javascript.
SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts.
Tasakis, Rafail Nikolaos; Samaras, Georgios; Jamison, Anna; Lee, Michelle; Paulus, Alexandra; Whitehouse, Gabrielle; Verkoczy, Laurent; Papavasiliou, F Nina; Diaz, Marilyn.
  • Tasakis RN; Division of Immune Diversity, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Samaras G; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.
  • Jamison A; Division of Immune Diversity, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lee M; Program of Translational Medical Research, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Paulus A; The Nightingale-Bamford School, New York, NY, United States of America.
  • Whitehouse G; Cornell University, Ithaca, NY, United States of America.
  • Verkoczy L; The Nightingale-Bamford School, New York, NY, United States of America.
  • Papavasiliou FN; The Nightingale-Bamford School, New York, NY, United States of America.
  • Diaz M; San Diego Biomedical Research Institute (SDBRI), San Diego, CA, United States of America.
PLoS One ; 16(7): e0255169, 2021.
Article in English | MEDLINE | ID: covidwho-1323022
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
Since the first case of COVID-19 in December 2019 in Wuhan, China, SARS-CoV-2 has spread worldwide and within a year and a half has caused 3.56 million deaths globally. With dramatically increasing infection numbers, and the arrival of new variants with increased infectivity, tracking the evolution of its genome is crucial for effectively controlling the pandemic and informing vaccine platform development. Our study explores evolution of SARS-CoV-2 in a representative cohort of sequences covering the entire genome in the United States, through all of 2020 and early 2021. Strikingly, we detected many accumulating Single Nucleotide Variations (SNVs) encoding amino acid changes in the SARS-CoV-2 genome, with a pattern indicative of RNA editing enzymes as major mutators of SARS-CoV-2 genomes. We report three major variants through October of 2020. These revealed 14 key mutations that were found in various combinations among 14 distinct predominant signatures. These signatures likely represent evolutionary lineages of SARS-CoV-2 in the U.S. and reveal clues to its evolution such as a mutational burst in the summer of 2020 likely leading to a homegrown new variant, and a trend towards higher mutational load among viral isolates, but with occasional mutation loss. The last quartile of 2020 revealed a concerning accumulation of mostly novel low frequency replacement mutations in the Spike protein, and a hypermutable glutamine residue near the putative furin cleavage site. Finally, end of the year data and 2021 revealed the gradual increase to prevalence of known variants of concern, particularly B.1.1.7, that have acquired additional Spike mutations. Overall, our results suggest that predominant viral genomes are dynamically evolving over time, with periods of mutational bursts and unabated mutation accumulation. This high level of existing variation, even at low frequencies and especially in the Spike-encoding region may become problematic when super-spreader events, akin to serial Founder Events in evolution, drive these rare mutations to prominence.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Genome, Viral / Founder Effect / Evolution, Molecular / Pandemics / SARS-CoV-2 / COVID-19 / Mutation Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: North America Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0255169

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Genome, Viral / Founder Effect / Evolution, Molecular / Pandemics / SARS-CoV-2 / COVID-19 / Mutation Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: North America Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0255169